mechlorethamine gel — CareFirst (Caremark)
Primary cutaneous marginal zone lymphoma
Initial criteria
- Authorization may be granted for the treatment of primary cutaneous marginal zone or follicle center lymphoma.
Reauthorization criteria
- Authorization may be granted for continued treatment when there is no evidence of unacceptable toxicity or disease progression while on the current regimen.
Approval duration
12 months